FIELD: chemistry.
SUBSTANCE: invention relates to cyclic depsipeptides of Formula (1A1-1) where each pyrazole is independently and separately optionally substituted by at least one substituent selected from C1-C6 alkyl, halogen, cyano, C1-C6 haloalkyl, C3-C6 cycloalkyl optionally substituted by at least one substituent selected from fluoro, chloro, methyl and methoxy; C1-C6 alkoxy phenyl optionally substituted with at least one substituent selected from halogen and methoxy; -C1-cyclopropyl; C2-C6 alkynyl optionally substituted with cyclopropyl or phenyl; and pyrrole optionally substituted with at least one substituent selected from cyano and methyl. Also provided are compositions comprising said depsipeptides.
EFFECT: cyclic depsipeptides of formula (1A1-1) are intended for the treatment of endoparasitic infection in animals, in particular endoparasitic infection caused by a filarial parasite such as Dirofiliaria.
11 cl, 12 tbl
Title | Year | Author | Number |
---|---|---|---|
NEW CYCLIC PEPTIDE COMPOUNDS | 2006 |
|
RU2423377C2 |
METHOD FOR SYNTHESIS OF CYCLIC DEPSIPEPTIDES | 2018 |
|
RU2817013C1 |
MACROHETEROCYCLIC NUCLEOSIDE DERIVATIVES AND ANALOGUES THEREOF, PRODUCTION AND USE | 2017 |
|
RU2731385C1 |
IMMUNOMODULATORY AZALIDES BASED ON UREA | 2021 |
|
RU2811591C1 |
MACROCYCLIC UREA AND SULPHAMIDE DERIVATIVES AS TAFIa INHIBITORS | 2009 |
|
RU2502736C2 |
REGULATORS-DERIVATIVES OF STEROIDS, METHODS OF THEIR OBTAINING AND THEIR USE | 2019 |
|
RU2797408C2 |
METHOD OF PRODUCING (13E)-(8R,11R,12R,15R)-11,15 DIHJDROXJ-16,16,19-TRIMETHYL-9-OXO-13,18-PROSTADIEN ACID OR (13E)-(8R,11R,12R,15S,16RS)-11,15-DIHYDROXY-16,19-DIMETHYL-9-OXO-13,18-PROSTADIEN ACID OR THEIR PHYSIOLOGICALLY COMPATIBLE SALTS | 0 |
|
SU1218925A3 |
ANTHELMINTHIC DEPSIPEPTIDE COMPOUNDS | 2016 |
|
RU2715556C2 |
PIPERIDINE DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2016 |
|
RU2730508C2 |
THERAPEUTIC PEPTIDES | 2010 |
|
RU2548905C2 |
Authors
Dates
2021-04-28—Published
2018-11-28—Filed